News & Analysis
- - - Categories
    - News & Analysis
    - Long Reads
    - Opinion
  - - Topics
    - Copyright, designs & trademarks
    - Finance & valuation
    - FRAND/SEPs
    - Law & policy
    - Licensing
    - Litigation
    - Trade secrets
    - Transactions
  - - Regions
    - Africa & Middle East
    - Asia-Pacific
    - Europe
    - Latin America & Caribbean
    - North America
Reports
- - - Reports
    - Special Reports
    - Panel Reports
    - Reports Centre
Data & Tools
- - - Data
    - Patent 1000 Analytics
    - Data Analysis
    - Data Hub
  - - Tools
    - GTDT
Rankings
- - - IAM Patent 1000
    - Introduction
    - All Firms
    - All Individuals
  - - IAM Strategy 300
    - Introduction
    - All individuals
  - - Global Leaders
    - IAM Global Leaders
    - Strategy 300 Global Leaders
  - - IAM Analytics
    - Patent 1000 Analytics
Insight
- - - Insight
    - Guides
    - Regional Reviews
    - Market Insight
  - - Hub
    - SEP/FRAND
Events
- - - Events
    - IAM & IPBC events
    - Diary
IAM Market
- Visit WTR
- About
- Archive
Login | Register
Subscribe Now

Home
Organisation: Abbott Laboratories

Organisation: Abbott Laboratories

Data shows New Jersey district court’s key for biopharma patent litigation

We have scoured Docket Navigator for must-know metrics on case filing trends, rulings on important motions, injunctive relief and damages awards

12 December 2022

Unlock unlimited access to all IAM content